Cryo Cell International Inc (CCEL) Institutional Ownership

Ownership Summary

Cryo Cell International Inc (NYSE:CCEL) has 17 institutional investors with active 13F positions as of December 2025.

• Collectively, these holders controlled 12.2% of Cryo Cell International's outstanding shares in December 2025, down from 12.2% in September 2025.
• Their total shares held in CCEL increased 0.49% quarter over quarter, and separately, investors owning Cryo Cell International decreased 19.05% from a year ago.
• Of these 17 holders, 6 added to their stakes in Cryo Cell International, 3 trimmed positions, and 8 made no changes.
• Altogether, these fund groups held 982.9K shares in CCEL by December 2025, up by 4.75K shares quarter on quarter, and down 51.0K shares year over year.
• SFI Advisors, LLC is the top holder of Cryo Cell International as of December 31, 2025, with 165.3K shares representing 2.05% of outstanding stock.
• Top purchasers of CCEL stock for the quarter ending December 2025 included VANGUARD CAPITAL MANAGEMENT LLC (161.52K), VANGUARD FIDUCIARY TRUST CO (23.35K), BlackRock, Inc. (1.12K), UBS Group AG (459).
• Top sellers of CCEL stock for the quarter ending December 2025 included GEODE CAPITAL MANAGEMENT, LLC (9.55K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.24K).
• Cryo Cell International's 10 largest shareholders as of December 2025 include SFI Advisors, LLC (165.3K), VANGUARD CAPITAL MANAGEMENT LLC (161.52K), MassMutual Private Wealth & Trust, FSB (111.04K), GEODE CAPITAL MANAGEMENT, LLC (43.62K), VANGUARD FIDUCIARY TRUST CO (23.35K), BlackRock, Inc. (13.98K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.02K), OSAIC HOLDINGS, INC. (2.5K), UBS Group AG (672), Morgan Stanley (601) per Business Quant data.